1.70
price down icon0.58%   -0.01
after-market Dopo l'orario di chiusura: 1.70
loading
Precedente Chiudi:
$1.71
Aprire:
$1.72
Volume 24 ore:
373.77K
Relative Volume:
0.73
Capitalizzazione di mercato:
$244.72M
Reddito:
$34.16M
Utile/perdita netta:
$-50.62M
Rapporto P/E:
-3.3465
EPS:
-0.508
Flusso di cassa netto:
$703.00K
1 W Prestazione:
-6.59%
1M Prestazione:
+5.59%
6M Prestazione:
-3.95%
1 anno Prestazione:
-58.13%
Intervallo 1D:
Value
$1.68
$1.795
Intervallo di 1 settimana:
Value
$1.59
$1.855
Portata 52W:
Value
$1.22
$4.87

Omniab Inc Stock (OABI) Company Profile

Name
Nome
Omniab Inc
Name
Telefono
510-250-7800
Name
Indirizzo
5980 HORTON STREET, EMERYVILLE
Name
Dipendente
114
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
OABI's Discussions on Twitter

Confronta OABI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OABI
Omniab Inc
1.70 231.77M 34.16M -50.62M 703.00K -0.508
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Omniab Inc Stock (OABI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-29 Iniziato RBC Capital Mkts Outperform
2023-04-21 Iniziato The Benchmark Company Buy
2023-04-13 Iniziato Craig Hallum Buy
2023-02-22 Iniziato Cowen Outperform
2023-02-13 Iniziato H.C. Wainwright Buy
2022-12-20 Iniziato Truist Buy
2022-12-16 Iniziato Credit Suisse Outperform
2022-11-29 Iniziato SVB Leerink Outperform
2022-11-28 Iniziato Stifel Buy
Mostra tutto

Omniab Inc Borsa (OABI) Ultime notizie

pulisher
Oct 16, 2025

Risk vs reward if holding onto OmniAb Inc. Equity WarrantMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Does OmniAb Inc. show high probability of reboundMarket Performance Recap & Stock Portfolio Risk Management - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Using Bollinger Bands to evaluate OmniAb Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

OmniAb to Participate in Three Investor Conferences in November - Yahoo Finance

Oct 16, 2025
pulisher
Oct 15, 2025

Will OmniAb Inc. stock continue dividend increasesJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Using data models to predict OmniAb Inc. Equity Warrant stock movementJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What momentum shifts mean for OmniAb Inc. Equity Warrant2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Applying Elliott Wave Theory to OmniAb Inc. Equity WarrantQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Signal strength of OmniAb Inc. stock in tech scanners2025 Valuation Update & Advanced Technical Analysis Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Quantitative breakdown of OmniAb Inc. recent moveDip Buying & Fast Momentum Stock Entry Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will OmniAb Inc. Equity Warrant stock deliver consistent dividendsJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Automated trading signals detected on OmniAb Inc.Weekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Published on: 2025-10-15 04:35:34 - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Evaluating OmniAb Inc. Equity Warrant with trendline analysisJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

OmniAb (NASDAQ:OABI) Receives Sell (E+) Rating from Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 14, 2025

OmniAb to Report Third Quarter 2025 Financial Results on November 4 - PharmiWeb.com

Oct 14, 2025
pulisher
Oct 14, 2025

Press Release: OmniAb to Report Third Quarter 2025 Financial Results on November 4 - 富途牛牛

Oct 14, 2025
pulisher
Oct 14, 2025

How OmniAb Inc. stock compares to industry benchmarksQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Technical analysis overview for OmniAb Inc. stock2025 Trading Recap & Technical Entry and Exit Alerts - newser.com

Oct 14, 2025
pulisher
Oct 12, 2025

Will OmniAb Inc. stock go up soonSell Signal & AI Powered Market Entry Strategies - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Can swing trading help recover from OmniAb Inc. lossesJuly 2025 Update & Daily Chart Pattern Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Live market analysis of OmniAb Inc.Volume Spike & Precise Buy Zone Identification - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

OmniAb, Inc. (NASDAQ:OABI) Not Lagging Industry On Growth Or Pricing - simplywall.st

Oct 10, 2025
pulisher
Oct 10, 2025

What institutional flow reveals about OmniAb Inc.Earnings Growth Report & Low Risk Entry Point Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Can Filatex India Limited Stock Sustain Its Uptrend in a Bear MarketBreakout Stock Watch & Low Cost Investment Portfolio - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

OmniAb Inc. Equity Warrant stock trend outlook and recovery pathJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Understanding OmniAb Inc.’s price movementTrade Risk Report & Risk Controlled Daily Plans - newser.com

Oct 09, 2025

Omniab Inc Azioni (OABI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Omniab Inc Azioni (OABI) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Love Steven
Director
May 14 '25
Buy
1.46
25,000
36,500
38,333
HIGGINS JOHN L
Director
May 12 '25
Buy
1.44
65,000
93,600
2,831,887
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Option Exercise
0.00
36,458
0
3,815,618
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Sale
2.00
19,382
38,764
3,796,236
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Option Exercise
0.00
13,542
0
370,418
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Sale
2.00
7,206
14,412
363,212
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Option Exercise
0.00
13,542
0
231,034
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Sale
2.00
7,206
14,412
223,828
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Capitalizzazione:     |  Volume (24 ore):